Actively Recruiting
A Dose-ranging Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Galvokimig in Adult Study Participants With Atopic Dermatitis
Led by UCB Biopharma SRL · Updated on 2026-05-08
160
Participants Needed
57
Research Sites
114 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The purpose of the study is to evaluate the dose-response relationship of galvokimig compared with placebo in study participants with moderate-to-severe atopic dermatitis (AtD).
CONDITIONS
Official Title
A Dose-ranging Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Galvokimig in Adult Study Participants With Atopic Dermatitis
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Participant must be aged greater than or equal (≥) 18 years at the time of signing the informed consent
- Participant has chronic atopic dermatitis present for at least 1 year prior to starting the study
- Validated Investigator Global Assessment (vIGA) score ≥3 at Screening and Baseline
- Eczema Area and Severity Index (EASI) score ≥16 at both Screening and Baseline
- Peak Pruritus Numerical Rating Scale (PP-NRS) score of ≥4 at both Screening and Baseline
- Atopic dermatitis involvement of ≥10% body surface area at both Screening and Baseline
- Documented recent history (within 6 months prior to Screening) of inadequate response to topical treatments or topical treatments medically inadvisable and candidate for systemic therapy
You will not qualify if you...
- History or presence of medical or psychiatric conditions that pose a risk or interfere with study participation
- Active dermatologic conditions that could confuse diagnosis or interfere with treatment assessment
- Presence or family history of inflammatory bowel disease
- History of chronic or serious infections within 6 months prior to Baseline
- Meeting tuberculosis exclusion criteria
- Previous treatment with galvokimig
- Relevant safety events from interleukin-13 biologic response modifiers requiring treatment change
- Use of systemic therapies (except biologics), topical therapies, or other treatments for atopic dermatitis within 4 weeks prior to Baseline
- Use of biologic agents within 3 months prior to Baseline
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 57 locations
1
Atd002 52021
Oceanside, California, United States, 92056
Actively Recruiting
2
Atd002 52008
Santa Monica, California, United States, 90404
Actively Recruiting
3
Atd002 52013
Boca Raton, Florida, United States, 33486
Actively Recruiting
4
Atd002 52007
Coral Gables, Florida, United States, 33134
Actively Recruiting
5
Atd002 52003
Miami, Florida, United States, 33133
Actively Recruiting
6
Atd002 52015
Savannah, Georgia, United States, 31419
Actively Recruiting
7
Atd002 52017
Chicago, Illinois, United States, 60611
Actively Recruiting
8
Atd002 52018
Wheaton, Illinois, United States, 60189
Actively Recruiting
9
Atd002 52012
New Albany, Indiana, United States, 47150
Actively Recruiting
10
Atd002 52014
Bowling Green, Kentucky, United States, 42104
Actively Recruiting
11
Atd002 52001
Troy, Michigan, United States, 48084
Actively Recruiting
12
Atd002 52009
Troy, Michigan, United States, 48084
Actively Recruiting
13
Atd002 52010
Omaha, Nebraska, United States, 68144
Actively Recruiting
14
Atd002 52020
The Bronx, New York, United States, 10455
Actively Recruiting
15
Atd002 52019
Philadelphia, Pennsylvania, United States, 19114
Actively Recruiting
16
Atd002 52005
Dallas, Texas, United States, 75230
Actively Recruiting
17
Atd002 52016
Frisco, Texas, United States, 75033
Actively Recruiting
18
Atd002 52011
Frisco, Texas, United States, 75034
Actively Recruiting
19
Atd002 52004
Sugar Land, Texas, United States, 77479
Actively Recruiting
20
Atd002 41004
Lovech, Bulgaria
Actively Recruiting
21
Atd002 41001
Pleven, Bulgaria
Actively Recruiting
22
Atd002 41007
Plovdiv, Bulgaria
Actively Recruiting
23
Atd002 41002
Sevlievo, Bulgaria
Actively Recruiting
24
Atd002 41005
Sofia, Bulgaria
Actively Recruiting
25
Atd002 41006
Sofia, Bulgaria
Actively Recruiting
26
Atd002 51006
Hamilton, Canada
Actively Recruiting
27
Atd002 51007
Toronto, Canada
Actively Recruiting
28
Atd002 42002
Náchod, Czechia
Actively Recruiting
29
Atd002 42001
Prague, Czechia
Actively Recruiting
30
Atd002 42004
Prague, Czechia
Actively Recruiting
31
Atd002 42005
Prague, Czechia
Actively Recruiting
32
Atd002 43001
Bad Bentheim, Germany
Actively Recruiting
33
Atd002 43002
Frankfurt, Germany
Actively Recruiting
34
Atd002 43004
Leipzig, Germany
Actively Recruiting
35
Atd002 43007
Mahlow, Germany
Actively Recruiting
36
Atd002 44003
Budapest, Hungary
Actively Recruiting
37
Atd002 21001
Habikino, Japan
Actively Recruiting
38
Atd002 21007
Nagoya, Japan
Actively Recruiting
39
Atd002 21005
Sakai, Japan
Actively Recruiting
40
Atd002 21008
Sapporo, Japan
Actively Recruiting
41
Atd002 21004
Tachikawa-shi, Japan
Actively Recruiting
42
Atd002 21006
Yokohama, Japan
Actively Recruiting
43
Atd002 45001
Katowice, Poland
Actively Recruiting
44
Atd002 45003
Krakow, Poland
Actively Recruiting
45
Atd002 45007
Krakow, Poland
Actively Recruiting
46
Atd002 45010
Krakow, Poland
Actively Recruiting
47
Atd002 45014
Krakow, Poland
Actively Recruiting
48
Atd002 45013
Lodz, Poland
Actively Recruiting
49
Atd002 45005
Sosnowiec, Poland
Actively Recruiting
50
Atd002 45009
Tarnów, Poland
Actively Recruiting
51
Atd002 45002
Warsaw, Poland
Actively Recruiting
52
Atd002 45004
Warsaw, Poland
Actively Recruiting
53
Atd002 45006
Warsaw, Poland
Actively Recruiting
54
Atd002 45008
Wroclaw, Poland
Actively Recruiting
55
Atd002 46004
London, United Kingdom
Actively Recruiting
56
Atd002 46007
London, United Kingdom
Actively Recruiting
57
Atd002 46003
Salford, United Kingdom
Actively Recruiting
Research Team
U
UCB Cares
CONTACT
U
UCB Cares
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
4
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here